Wyeth Credit Rating

Resultados 1 - 50 de 69

Página de 2 Next

Filtrar por:

Fecha	Tipo de Reporte	Título	Fuente
13 Dec 2023	Rating Action	Moody's downgrades Pfizer to A2; affirms Prime-1; stable outlook	Moody's Investors Service
27 Jul 2023	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
13 Mar 2023	Rating Action	Moody's affirms Pfizer's A1 rating; revises outlook to negative	Moody's Investors Service
18 Nov 2022	Rating Action	Moody's upgrades Pfizer to A1; outlook is stable	Moody's Investors Service
04 Oct 2022	Announcement of Periodic Review	Moody's announces completion of a periodic review for a group of Pharmaceutical issuers	Moody's Investors Service
14 Dec 2021	Rating Action	Moody's affirms Pfizer's A2 rating; revises outlook to positive	Moody's Investors Service
10 Nov 2021	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Pfizer Inc.	Moody's Investors Service
15 Dec 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Pfizer Inc.	Moody's Investors Service
16 Nov 2020	Rating Action	Moody's downgrades Pfizer to A2 from A1 following Upjohn separation; stable outlook	Moody's Investors Service
14 Jan 2020	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Pfizer Inc.	Moody's Investors Service
29 Jul 2019	Rating Action	Moody's reviews Pfizer's A1 rating for downgrade; affirms P-1 rating	Moody's Investors Service
15 Feb 2019	Announcement of Periodic Review	Moody's announces completion of a periodic review of ratings of Pfizer Inc.	Moody's Investors Service
26 Sep 2016	Rating Action	Moody's affirms Pfizer's ratings; changes outlook to stable	Moody's Investors Service
22 Aug 2016	Rating Action	Moody's affirms Pfizer at A1/P-1; outlook remains negative	Moody's Investors Service
16 May 2016	Rating Action	Moody's affirms Pfizer's A1/P-1 ratings; outlook now negative	Moody's Investors Service
06 Apr 2016	Rating Action	Moody's affirms Pfizer's A1/Prime-1 ratings; stable outlook	Moody's Investors Service
23 Nov 2015	Rating Action	Moody's affirms Pfizer's A1 rating on Allergan deal; stable outlook	Moody's Investors Service
05 Feb 2015	Rating Action	Moody's affirms Pfizer's A1 rating; stable outlook	Moody's Investors Service
22 Mar 2012	Announcement	Moody's Disclosures on Credit Ratings of Pfizer Inc.	Moody's Investors Service
13 Oct 2010	Special Comment	Global Pharmaceutical Issuer Scorecard	Moody's Investors Service
26 Mar 2010	Credit Opinion	Wyeth	Moody's Investors Service
19 Nov 2009	Announcement	Moody's: Outlook Negative for Global Pharmaceutical Industry	Moody's Investors Service
05 Nov 2009	Rating Action	Moody's upgrades Wyeth to A1 based on Pfizer guarantee	Moody's Investors Service
19 Oct 2009	Issuer Comment	Moody's Covenant Office comments that Wyeth bondholder protections are not substantially weaker if consent solicitation is successful and Pfizer guarantee is executed	Moody's Investors Service
16 Oct 2009	Announcement	Moody's continues Wyeth review after Pfizer consent solicitation	Moody's Investors Service
15 Oct 2009	Rating Action	Moody's lowers Pfizer to A1; continues review of Wyeth's A3	Moody's Investors Service
24 Mar 2009	Covenant Quality Assessment	Wyeth - Notes issued under April 10, 1992 Indenture. Coupon and maturity range: 5.25 – 7.25%, 2011-2037. See Appendix C for a complete list of Reference Securities.	Moody's Investors Service
26 Jan 2009	Rating Action	Moody's reviews Pfizer for downgrade, Wyeth for upgrade	Moody's Investors Service
31 Jan 2008	Rating Action	Moody's affirms Wyeth's A3/Prime-2, revises outlook to stable	Moody's Investors Service
07 Jan 2008	Analysis	Wyeth	Moody's Investors Service
19 Dec 2007	Rating Action	Moody's assigns A3 rating to Wyeth's $3B credit facility	Moody's Investors Service
28 Sep 2007	Rating Action	Moody's confirms Wyeth's A3/Prime-2; positive outlook	Moody's Investors Service
01 Aug 2007	Issuer Comment	Moody's comments on Wyeth: Recent Updates on Protonix & Pristiq	Moody's Investors Service
04 Jun 2007	Rating Action	Moody's reviews Wyeth's A3/Prime-2 ratings for possible upgrade	Moody's Investors Service
22 Mar 2007	Rating Action	Moody's assigns A3 to Wyeth's new sr. notes; positive outlook	Moody's Investors Service
13 Dec 2006	Rating Action	Moody's upgrades Wyeth to A3, positive outlook	Moody's Investors Service
11 Dec 2006	Liquidity Risk Assessment	Wyeth	Moody's Investors Service
22 Nov 2006	Corporate Governance Assmt	Wyeth	Moody's Investors Service
01 Nov 2006	Rating Action	Moody's reviews Wyeth's Baa1 for possible upgrade	Moody's Investors Service
18 May 2006	Rating Action	MOODY'S REVISES WYETH'S RATING OUTLOOK TO POSITIVE FROM DEVELOPING; AFFIRMS RATINGS (Baa1/Prime-2)	Moody's Investors Service
20 Jan 2006	Corp Governance Assmt-Update	Wyeth	Moody's Investors Service
22 Nov 2005	Announcement	MOODY'S REPORTS: FDA DELAYS ADD TO NEGATIVE U.S. PHARMACEUTICAL OUTLOOK	Moody's Investors Service
09 Nov 2005	Rating Action	MOODY'S AFFIRMS WYETH'S Baa1/Prime-2 RATINGS; ASSIGNS Baa1 RATING TO NEW SENIOR UNSECURED NOTE OFFERING; RATING OUTLOOK REMAINS DEVELOPING	Moody's Investors Service
10 Oct 2005	Rating Action	MOODY'S ASSIGNS Baa1 RATING TO WYETH'S NEW BANK CREDIT FACILITY; RATING OUTLOOK REMAINS DEVELOPING	Moody's Investors Service
12 Sep 2005	Rating Action	MOODY'S ADJUSTS RATING OF MISSOURI STATE ENVIRONMENTAL IMPROVEMENT AND ENERGY RESOURCES AUTHORITY INDUSTRIAL REVENUE BOND, CUSIP No. 606906BW(4) TO Aa3 FROM Baa1	Moody's Investors Service
08 Feb 2005	Rating Action	MOODY'S AFFIRMS RATINGS OF WYETH (Baa1 LONG TERM; PRIME-2 SHORT TERM); REVISES OUTLOOK TO DEVELOPING FROM NEGATIVE	Moody's Investors Service
06 Dec 2004	Rating Action	MOODY'S: REPORT DETAILS KEY PHARMACEUTICAL RATING FACTORS	Moody's Investors Service
21 Sep 2004	Corporate Governance Assmt	Wyeth	Moody's Investors Service
31 Mar 2004	Analysis	Wyeth	Moody's Investors Service
31 Mar 2004	Financial Statement Ratios	Wyeth	Moody's Investors Service

Resultados 1 - 50 de 69

Página de 2 Next

Estudios & Calificaciones

Productos & Soluciones

Noticias & Eventos

Usuarios Registrados

¿No se ha registrado?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: